MEDICA – Provision for Updating the 2012 Registration Document and Document Information on the Merger of Medica Korian

Regulatory News:

MEDICA (Paris:MDCA), leading provider of long- and short-term dependency care, today announces the availability of the update of its 2012 Registration Document filed with the Autorité des Marchés Financiers ("AMF") Wednesday, February 5, 2014 under No. D.13-0383-A01 and the provision of the information document relating to the merger between MEDICA and KORIAN under Article 212-4 3° of the General Regulations of the AMF and registered by the AMF Wednesday, February 5, 2014 under No. E.14-003.

These documents are available on the AMF website (www.amf-france.org) as well as company’s website (www.groupemedica.com) in space "Shareholders and Investors" heading "Regulated Information".

Copies of these documents are also available at the company's headquarters:
39, rue Gouverneur General Félix Eboué 92130 Issy-les-Moulineaux.

ABOUT MEDICA

Formed in 1968, MEDICA is a leading provider of long- and short-term dependency care. It operates both in the long-term care sector, with nursing homes in France, Belgium and Italy, and in the post- acute and psychiatric care sector. In its three geographical platforms, the Group now has a total of over 23,000 beds and employs over 15,000 people.

MEDICA has been listed on the NYSE Euronext Paris stock exchange since February 2010 – Compartment B – Eligible for the Deferred Settlement Service, long only.

MEDICA is included in the SBF 120, Euronext CAC Healthcare, MSCI France Small Cap and Gaia indices.

Code: MDCA - ISIN: FR0010372581 - Reuters: MDCA PA - Bloomberg: MDCA FP
Website: www.groupemedica.com

Important information

This press release does not constitute and shall not be construed as an offer or the solicitation of an offer to purchase, sell or exchange any securities of KORIAN and MEDICA. In addition, it does not constitute an offer or the solicitation of an offer to purchase, sell or exchange of securities in any jurisdiction (including the US and the United Kingdom) in which it would be unlawful or subject to registration or qualification under the laws of such jurisdiction.

In connection with the proposed transaction, the required information documents will be filed with the Autorité des Marchés Financiers ("AMF”). Investors and shareholders are strongly advised to read, when available, the information documents that have been filed with the AMF and any other relevant document that has been filed with the AMF as well as any related amendment if any and/or supplements because they will contain important information.

Shareholders and investors may obtain free copies of documents filed with the AMF at www.amf-france.org.

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA